Page last updated: 2024-11-06

lysergic acid diethylamide and Laryngeal Neoplasms

lysergic acid diethylamide has been researched along with Laryngeal Neoplasms in 1 studies

Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.

Laryngeal Neoplasms: Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gayer, J1
PrĂ­bys, R1

Other Studies

1 other study available for lysergic acid diethylamide and Laryngeal Neoplasms

ArticleYear
In vitro induced disappearance of nucleoli in cells treated with LSD-25.
    Experientia, 1970, Dec-15, Volume: 26, Issue:12

    Topics: Carcinoma; Cell Line; Cell Nucleolus; Culture Techniques; Humans; Laryngeal Neoplasms; Lysergic Acid

1970